Servier Canada

Advancing Targeted Care for Adults with Genetically Defined Acute Myeloid Leukemia (AML) 

Servier strengthens its growth momentum in 2024–2025 and accelerates progress toward its 2030 strategic ambition

Ontario becomes the first province to publicly reimburse the first targeted oral therapy for adults with Grade 2 IDH-mutant glioma

World Cholangiocarcinoma Day 

On World Cancer Day, Servier Canada is United by Unique

Servier Canada Recognized as a Great Place To Work®

Targeted therapies as cancer treatments

Servier supports World Acute Myeloid Leukemia Day on April 21

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030

Canadian Brain Cancer Awareness Day